Minocycline hepatitis

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 8, 2008, Pages 796-799

  Ford, Thomas J ^a   Dillon, John F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Autoimmune disease; Autoimmune hepatitis; Chronic active hepatitis; Hepatitis; Iatrogenic disease; Minocycline; Monitoring liver function

Indexed keywords

ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; MINOCYCLINE; UROBILINOGEN; ANTIINFECTIVE AGENT;

ACNE VULGARIS; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CASE REPORT; DRUG WITHDRAWAL; FATIGUE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENERAL CONDITION IMPROVEMENT; HUMAN; JAUNDICE; LIVER DYSFUNCTION; MALAISE; PRIORITY JOURNAL; TOXIC HEPATITIS; TREATMENT DURATION; TREATMENT WITHDRAWAL; URINALYSIS;

ACNE VULGARIS; ADULT; ANTI-BACTERIAL AGENTS; FEMALE; HEPATITIS, AUTOIMMUNE; HEPATITIS, TOXIC; HUMANS; MINOCYCLINE;

EID: 52749092135     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f493c5     Document Type: Article

References (35)

1. Gottlieb A. Safety of minocycline for acne. Lancet 1997; 349:374.
2. Garner SE, Eady EA, Popescu C, Newton J, Li Wan Po A. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev 2003; 1:CD002086.
3. McManus P, Iheanacho I. Don't use minocycline as first line oral antibiotic in acne. Br Med J 2007; 334:154.
4. Anonymous. Is minocycline overused in acne? Drug Ther Bull 2006; 44:60-62.
5. Crosson J, Stillman MT. Minocycline-related lupus erythematosus with associated liver disease. J Am Acad Dermatol. 1997; 36:867-878.
6. Chamberlain MC, Schwarzenberg SJ, Akin EU, Kurth MH. Minocycline-induced autoimmune hepatitis with subsequent cirrhosis. J Pediatr Gastroenterol Nutr 2006; 42:232-235.
7. Elkayam O,Yaron M, Caspi D. Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum 1999; 28:392-397.
8. Cunliffe WJ. Minocycline for acne: doctors should not change the way they prescribe for acne. [Letter] Br Med J 1996; 312:1101.
9. Rutenberg AM, Pinkes S. Hepatotoxicity of intravenous aureomycin. N Engl J Med 1952; 247:797-800.
10. UK Medicines and Healthcare products Regulatory Agency. Minocycline. Drug Analysis Prints: Data on suspected adverse drug reactions [Online]. 2006 May 26 [cited 2007 Mar]; Available from URL: http:// www.mhra.gov.uk/
11. Schultz JC, Adamson JS Jr, Workman WW, Norman TD. Fatal liver disease and intravenous administration of tetracycline in high dosage. N Engl J Med 1963; 269:999-1004.
12. Burette A, Finet C, Prigogine T, DeRoy G, Deltenre M. Acute hepatic injury associated with minocycline. Arch Intern Med 1984; 144: 1491-1492.
13. Boudreaux JP, Hayes DH, Mizrahi S, Hussey J, Regenstein F, Balart L. Fulminant hepatic failure, hepatorenal syndrome and necrotising pancreatitis after minocycline hepatotoxicity. Transplant Proc 1993; 25:1873.
14. Min ID, Burke PA, Lewis WD, Jenkins RL. Acute hepatic failure associated with oral minocycline: a case report. Pharmacotherapy 1992; 12:68-72.
15. Knowles SR, Shapiro L, Shear NH. Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature. Arch Dermatol 1996; 132:934-939.
16. Davies MG, Kersey PJW. Acute hepatitis and exfoliative dermatitis associated with minocycline. Br Med J 1989; 298:1523-1524.
17. MacNeil M, Haase DA, Tremaine R, Marrie TJ. Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline. J Am Acad Dermatol 1997; 36:347-350.
18. Kaufmann D, Pichler W, Beer JH. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne. Arch Intern Med 1994; 154:1983-1984.
19. Shapiro LE, Knowles SR, Shear NH. Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis. J Am Acad Dermatol 1998; 38:132-133.
20. Disdier P, Granel B, Serratrice S, Weiller PJ. A teenager with rash and fever. Lancet 2001; 358:2046.
21. Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. Br Med J 1996; 312:169-172.
22. Eichenfield AH. Minocycline and autoimmunity. Curr Opin Pediatr 1999; 11:447-456.
23. Lawrenson RA, Seaman HE, Sundstrom A, Williams TJ, Farmer RD. Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data. Drug Saf 2000; 23:333-349.
24. Tumoana R. 'Minocycline induced autoimmune hepatitis and arthritis' BMJ Rapid response 18 September 1999. Response to comment on Gough et al. Br Med J 1996; 312:169-172.
25. Krawitt EL. Medical progress: autoimmune hepatitis. N Engl J Med 2006; 354:54-66.
26. Abe M, Furukawa S, Takayama S, Michitaka K, Minami H, Yamamoto K, et al. Drug-induced hepatitis with autoimmune features during minocycline therapy. Intern Med 2003; 42:48-52.
27. Goldstein NS, Bayati N, Silverman AL, Gordon SC. Minocycline as a cause of drug-induced autoimmune hepatitis. Report of four cases and comparison with autoimmune hepatitis. Am J Clin Pathol 2000; 114:591-598.
28. Elkayam O, Levartovsky D, Brautbar C, Yaron M, Burke M, Vardinon N, Caspi D. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Am J Med 1998; 105:484-487.
29. Bhat G, Jordan J Jr, Sokalski S, Bajaj V, Marshall R, Berkelhammer C. Minocycline-induced hepatitis with autoimmune features and neutropenia. J Clin Gastroenterol 1998; 27:74-75.
30. Malcolm A, Heap TR, Eckstein RP, Lunzer MR. Minocycline-induced liver injury. Am J Gastroenterol 1996; 91:1641-1643.
31. Teitelbaum JE, Perez-Atayde AR, Cohen M, Bousvaros A, Jonas MM. Minocycline-related autoimmune hepatitis: case series and literature review. Arch Pediatr Adolesc Med 1998; 152:1132-1136.
32. Herzog D, Hajoui O, Russo P, Alvarez F. Study of immune reactivity of minocycline-induced chronic active hepatitis. Dig Dis Sci 1997; 42:1100-1103.
33. Lawson TM, Amos N, Bulgen D, Williams BD. Minocycline-induced lupus: clinical features and response to rechallenge. Rheumatology 2001; 40:329-335.
34. Schlienger RG, Bircher AJ, Meier CR. Minocycline-induced lupus. A systematic review. Dermatology 2000; 200:223-231.
35. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31:929-938.